Literature DB >> 22471862

University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology.

Frederick A Schmitt1, Peter T Nelson, Erin Abner, Stephen Scheff, Gregory A Jicha, Charles Smith, Gregory Cooper, Marta Mendiondo, Deborah D Danner, Linda J Van Eldik, Allison Caban-Holt, Mark A Lovell, Richard J Kryscio.   

Abstract

Cognitively intact elderly research volunteers at the University of Kentucky have been recruited, followed longitudinally, and autopsied with extensive neuropathological evaluations since 1989. To date, the cohort has recruited 1,030 individuals with 552 participants being actively followed, 363 deceased, and 273 autopsied. An extensive database has been constructed with continuous updates that include textured clinical, neuropsychological, neuroimaging, and pathological information. The history, demographics, clinical observations, and pathological features of this research cohort are described. We also explain some of the evolving methodologies and the academic contributions that have been made due to this motivated group of older Kentuckians.

Entities:  

Mesh:

Year:  2012        PMID: 22471862      PMCID: PMC3409295          DOI: 10.2174/156720512801322591

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  77 in total

1.  Promoting interactions with basic scientists and clinicians: summary of the panel session.

Authors:  F A Schmitt; J P Miller; R J Kryscio
Journal:  Stat Med       Date:  2000 Jun 15-30       Impact factor: 2.373

2.  "Preclinical" AD revisited: neuropathology of cognitively normal older adults.

Authors:  F A Schmitt; D G Davis; D R Wekstein; C D Smith; J W Ashford; W R Markesbery
Journal:  Neurology       Date:  2000-08-08       Impact factor: 9.910

3.  The New Adult Reading Test-Revised: accuracy in estimating WAIS-R IQ scores obtained 3.5 years earlier from normal older persons.

Authors:  D T Berry; G S Carpenter; D A Campbell; F A Schmitt; K Helton; T Lipke-Molby
Journal:  Arch Clin Neuropsychol       Date:  1994-05       Impact factor: 2.813

4.  RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain.

Authors:  Peter T Nelson; Don A Baldwin; Wigard P Kloosterman; Sakari Kauppinen; Ronald H A Plasterk; Zissimos Mourelatos
Journal:  RNA       Date:  2005-12-22       Impact factor: 4.942

5.  Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognition.

Authors:  Kathryn P Riley; Gregory A Jicha; Daron Davis; Erin L Abner; Gregory E Cooper; Nancy Stiles; Charles D Smith; Richard J Kryscio; Peter T Nelson; Linda J Van Eldik; Frederick A Schmitt
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 6.  Human cerebral neuropathology of Type 2 diabetes mellitus.

Authors:  Peter T Nelson; Charles D Smith; Erin A Abner; Frederick A Schmitt; Stephen W Scheff; Gregory J Davis; Jeffrey N Keller; Gregory A Jicha; Daron Davis; Wang Wang-Xia; Adria Hartman; Douglas G Katz; William R Markesbery
Journal:  Biochim Biophys Acta       Date:  2008-08-22

7.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

8.  Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease.

Authors:  Stephen W Scheff; Douglas A Price; Frederick A Schmitt; Melissa A Scheff; Elliott J Mufson
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 9.  MicroRNAs (miRNAs) in neurodegenerative diseases.

Authors:  Peter T Nelson; Wang-Xia Wang; Bernard W Rajeev
Journal:  Brain Pathol       Date:  2008-01       Impact factor: 6.508

10.  Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques.

Authors:  R Katzman; R Terry; R DeTeresa; T Brown; P Davies; P Fuld; X Renbing; A Peck
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422

View more
  86 in total

1.  Expression profiling of precuneus layer III cathepsin D-immunopositive pyramidal neurons in mild cognitive impairment and Alzheimer's disease: Evidence for neuronal signaling vulnerability.

Authors:  Bin He; Sylvia E Perez; Sang H Lee; Stephen D Ginsberg; Michael Malek-Ahmadi; Elliott J Mufson
Journal:  J Comp Neurol       Date:  2020-05-05       Impact factor: 3.215

2.  Global Cerebral Atrophy Detected by Routine Imaging: Relationship with Age, Hippocampal Atrophy, and White Matter Hyperintensities.

Authors:  Omar M Al-Janabi; Pradeep Panuganti; Erin L Abner; Ahmed A Bahrani; Ronan Murphy; Shoshana H Bardach; Allison Caban-Holt; Peter T Nelson; Brian T Gold; Charles D Smith; Donna M Wilcock; Gregory A Jicha
Journal:  J Neuroimaging       Date:  2018-01-05       Impact factor: 2.486

3.  Clinically silent Alzheimer's and vascular pathologies influence brain networks supporting executive function in healthy older adults.

Authors:  Brian T Gold; Christopher A Brown; Jonathan G Hakun; Leslie M Shaw; John Q Trojanowski; Charles D Smith
Journal:  Neurobiol Aging       Date:  2017-06-24       Impact factor: 4.673

4.  Diagnostic accuracy and practice effects in the National Alzheimer's Coordinating Center Uniform Data Set neuropsychological battery.

Authors:  Melissa Mathews; Erin Abner; Richard Kryscio; Gregory Jicha; Gregory Cooper; Charles Smith; Allison Caban-Holt; Frederick A Schmitt
Journal:  Alzheimers Dement       Date:  2014-03-20       Impact factor: 21.566

5.  Clinico-Neuropathological Findings in the Oldest Old from the Georgia Centenarian Study.

Authors:  Jirayu Tanprasertsuk; Elizabeth J Johnson; Mary Ann Johnson; Leonard W Poon; Peter T Nelson; Adam Davey; Peter Martin; Aron K Barbey; Kathryn Barger; Xiang-Dong Wang; Tammy M Scott
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

6.  Post-acquisition processing confounds in brain volumetric quantification of white matter hyperintensities.

Authors:  Ahmed A Bahrani; Omar M Al-Janabi; Erin L Abner; Shoshana H Bardach; Richard J Kryscio; Donna M Wilcock; Charles D Smith; Gregory A Jicha
Journal:  J Neurosci Methods       Date:  2019-08-10       Impact factor: 2.390

7.  Risk of incident clinical diagnosis of Alzheimer's disease-type dementia attributable to pathology-confirmed vascular disease.

Authors:  Hiroko H Dodge; Jian Zhu; Randy Woltjer; Peter T Nelson; David A Bennett; Nigel J Cairns; David W Fardo; Jeffrey A Kaye; Deniz-Erten Lyons; Nora Mattek; Julie A Schneider; Lisa C Silbert; Chengjie Xiong; Lei Yu; Frederick A Schmitt; Richard J Kryscio; Erin L Abner
Journal:  Alzheimers Dement       Date:  2016-12-23       Impact factor: 21.566

8.  Age and Alzheimer's pathology disrupt default mode network functioning via alterations in white matter microstructure but not hyperintensities.

Authors:  Christopher A Brown; Yang Jiang; Charles D Smith; Brian T Gold
Journal:  Cortex       Date:  2018-04-19       Impact factor: 4.027

9.  Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer's disease.

Authors:  Sylvia E Perez; Bin He; Muhammad Nadeem; Joanne Wuu; Stephen W Scheff; Eric E Abrahamson; Milos D Ikonomovic; Elliott J Mufson
Journal:  Biol Psychiatry       Date:  2014-01-11       Impact factor: 13.382

10.  Neuroinflammatory phenotype in early Alzheimer's disease.

Authors:  Tiffany L Sudduth; Frederick A Schmitt; Peter T Nelson; Donna M Wilcock
Journal:  Neurobiol Aging       Date:  2012-10-09       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.